Complex endovascular aortic repair in inflammatory and infective perivisceral abdominal aortic aneurysms and thoracoabdominal aortic aneurysms (CEVARII) study is a collaborative international effort among vascular surgeons to establish a database on the global experience in the management of INAAs and IAAs. Ethical approval for the study was obtained from the Colorado Multiple Institutional Review Board (COMIRB) under protocol number 23-1533.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary Graft Patency
Timeframe: up to 36 months
Bowel Ischemia
Timeframe: 30 days
Presence of aortic aneurysm endoleak after surgery
Timeframe: up to 30 days
Aneurysm-related mortality (ARM)
Timeframe: up to 30 days
Conversion to Open Surgical Repair (OSR)
Timeframe: up to 30 days
Aortic rupture
Timeframe: up to 30 days.
Post-operative infection-related complication (IRC)
Timeframe: up to 24 months
The duration of preoperative, perioperative, and postoperative duration of anti-microbial or immunosuppressive pharmacologic therapies.
Timeframe: up to 36 months